Taking a patient's immune cells and targeting their cancer with them, which is called CAR T cell therapy, is showing promise ...

FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...

Axi-cel, tisa-cel, and brexu-cel were found comparable to other cellular therapy experiences for patients with B-cell ...

Researchers at Moffitt Cancer Center have found that tapping into the body's own immune system and activating a type of immune cell known as B cells, could be the key to boosting the effectiveness of ...

A pilot study presented at EBMT 2025 shows adoptive cell therapy using memory T lymphocytes effectively treats infections in ...

Despite the challenges, including what CSL CEO Paul McKenzie has described as a fragmented U.S. healthcare system, the blood ...

A study reporting on DiscGenics’ cell therapy phase 1 and 2 study has been selected as one of three of the best and most influential articles published in the International Journal of Spine Surgery in ...

The findings indicate that the currently approved 600-mg dose of intravenous ocrelizumab is optimal to significantly slow ...

Cell therapy is a field rife with innovation ... approval to begin its first phase 1 trial for its therapeutic for B-cell malignancies. Kelonia, which has been operating in stealth mode for ...

Former Bachelorette star Katie Thurston is sharing a major update on her cancer journey after having to put her treatments on ...

CAR-T cell therapy is an individualised treatment for ... for all adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large B-cell lymphoma ...

Gene therapy companies have faced numerous setbacks over the last few years. What will it take for gene therapies to fulfill ...